Literature DB >> 26761473

Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital.

Mariana Macedo Alvim1, Lidiane Ayres da Silva1, Isabel Cristina Gonçalves Leite1, Marcelo Silva Silvério1.   

Abstract

OBJECTIVE: To evaluate the incidence of potential drug-drug interactions in an intensive care unit of a hospital, focusing on antimicrobial drugs.
METHODS: This cross-sectional study analyzed electronic prescriptions of patients admitted to the intensive care unit of a teaching hospital between January 1 and March 31, 2014 and assessed potential drug-drug interactions associated with antimicrobial drugs. Antimicrobial drug consumption levels were expressed in daily doses per 100 patient-days. The search and classification of the interactions were based on the Micromedex® system.
RESULTS: The daily prescriptions of 82 patients were analyzed, totaling 656 prescriptions. Antimicrobial drugs represented 25% of all prescription drugs, with meropenem, vancomycin and ceftriaxone being the most prescribed medications. According to the approach of daily dose per 100 patient-days, the most commonly used antimicrobial drugs were cefepime, meropenem, sulfamethoxazole + trimethoprim and ciprofloxacin. The mean number of interactions per patient was 2.6. Among the interactions, 51% were classified as contraindicated or significantly severe. Highly significant interactions (clinical value 1 and 2) were observed with a prevalence of 98%.
CONCLUSION: The current study demonstrated that antimicrobial drugs are frequently prescribed in intensive care units and present a very high number of potential drug-drug interactions, with most of them being considered highly significant.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26761473      PMCID: PMC4738821          DOI: 10.5935/0103-507X.20150060

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  13 in total

1.  [The profile of antimicrobial utilization in a private hospital].

Authors:  Fernanda d'Athayde Rodrigues; Andréa Dâmaso Bertoldi
Journal:  Cien Saude Colet       Date:  2010-06

2.  [Stress ulcer prophylaxis in intensive care units: an observational multicenter study].

Authors:  André Sant'Ana Machado; Cassiano Teixeira
Journal:  Rev Bras Ter Intensiva       Date:  2006-09

Review 3.  [Drug utilization studies: a synthesis of articles published in Brazil and Latin America].

Authors:  Silvana Nair Leite; Mônica Vieira; Ana Paula Veber
Journal:  Cien Saude Colet       Date:  2008-04

4.  Infection with multi-resistant agents in the ICU: how to escape?

Authors:  Thiago Lisboa; Fabiano Nagel
Journal:  Rev Bras Ter Intensiva       Date:  2011-06

5.  Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors.

Authors:  Simon Seynaeve; Walter Verbrugghe; Brigitte Claes; Dirk Vandenplas; Dirk Reyntiens; Philippe G Jorens
Journal:  Am J Crit Care       Date:  2011-11       Impact factor: 2.228

6.  Mining clinical text for signals of adverse drug-drug interactions.

Authors:  Srinivasan V Iyer; Rave Harpaz; Paea LePendu; Anna Bauer-Mehren; Nigam H Shah
Journal:  J Am Med Inform Assoc       Date:  2013-10-24       Impact factor: 4.497

7.  [Mechanisms of rhabdomyolysis with statins].

Authors:  Maria Eliane Campos Magalhães
Journal:  Arq Bras Cardiol       Date:  2006-01-02       Impact factor: 2.000

8.  Characterization of drug prescriptions in an adult intensive care unit.

Authors:  Leandro Dos Santos Maciel Cardinal; Vanessa Terezinha Gubert de Matos; Glenda Mara Sousa Resende; Mônica Cristina Toffoli-Kadri
Journal:  Rev Bras Ter Intensiva       Date:  2012-06

9.  Incidence of adverse drug events in an academic hospital: a prospective cohort study.

Authors:  Hisham Aljadhey; Mansour A Mahmoud; Ahmed Mayet; Mashael Alshaikh; Yusuf Ahmed; Michael D Murray; David W Bates
Journal:  Int J Qual Health Care       Date:  2013-10-17       Impact factor: 2.038

10.  Patterns of antibacterials use in intensive care units.

Authors:  Edilson Floriano Dos Santos; Liana Lauria-Pires
Journal:  Rev Bras Ter Intensiva       Date:  2010-06
View more
  12 in total

1.  Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.

Authors:  Mina Nikanjam; Sariah Liu; Jincheng Yang; Razelle Kurzrock
Journal:  Oncologist       Date:  2017-04-19

2.  Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns.

Authors:  Mina Nikanjam; Harsh Patel; Razelle Kurzrock
Journal:  Oncoimmunology       Date:  2017-06-28       Impact factor: 8.110

Review 3.  Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Mary Grace Fitzmaurice; Adrian Wong; Hannah Akerberg; Simona Avramovska; Pamela L Smithburger; Mitchell S Buckley; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

4.  Comparing Important and Well-documented Potential Drug-Drug Interactions between Emergency, Medical, and Surgical ICUs of a Respiratory Referral Center.

Authors:  Zeinab Hosseinpoor; Behrooz Farzanegan; Shadi Baniasadi
Journal:  Indian J Crit Care Med       Date:  2022-05

5.  Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico.

Authors:  Olga Morales-Ríos; Luis Jasso-Gutiérrez; Alfonso Reyes-López; Juan Garduño-Espinosa; Onofre Muñoz-Hernández
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

6.  Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.

Authors:  Bhavika Ravindra Wagh; Deepa Dhananjay Godbole; Shubham Shivaji Deshmukh; Shivakumar Iyer; Prasanna R Deshpande
Journal:  Indian J Crit Care Med       Date:  2019-04

7.  Potential Drug-drug Interactions in Acute Ischemic Stroke Patients at the Neurological Intensive Care Unit.

Authors:  Dejan Z Aleksic; Slobodan M Jankovic; Milos N Mlosavljevic; Gordana L Toncev; Svetlana D Miletic Drakulic; Srdjan M Stefanovic
Journal:  Open Med (Wars)       Date:  2019-11-07

8.  Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study.

Authors:  Yu Hyeon Choi; In Hwa Lee; Mihee Yang; Yoon Sook Cho; Yun Hee Jo; Hye Jung Bae; You Sun Kim; June Dong Park
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

9.  Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit.

Authors:  Elisangela da Costa Lima; Barbara Dias Camarinha; Nathalia Cristina Ferreira Bezerra; Anderson Gonçalves Panisset; Raquel Belmino de Souza; Marcus Tolentino Silva; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

Review 10.  Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yu Na Han; Yeo Jin Choi; Sandy Jeong Rhie
Journal:  Healthcare (Basel)       Date:  2022-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.